The Study of a Novel Paeoniflorin-Converting Enzyme from Cunninghamella blakesleeana
Molecules · 2023
DOI: 10.3390/molecules28031289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Yiheng Ye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Technology & Business University, Beijing 100048, China. Hauptthemen laut MEDLINE: Cunninghamella, Paeonia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation and Beijing Municipal Education Committee.
Abstract (Originalsprache)
Paeoniflorin is a glycoside compound found in Paeonia lactiflora Pall that is used in traditional herbal medicine and shows various protective effects on the cardio-cerebral vascular system. It has been reported that the pharmacological effects of paeoniflorin might be generated by its metabolites. However, the bioavailability of paeoniflorin by oral administration is low, which greatly limits its clinical application. In this paper, a paeoniflorin-converting enzyme gene (G6046, GenBank accession numbers: OP856858) from Cunninghamella blakesleeana (AS 3.970) was identified by comparative analysis between MS analysis and transcriptomics. The expression, purification, enzyme activity, and structure of the conversion products produced by this paeoniflorin-converting enzyme were studied. The optimal conditions for the enzymatic activity were found to be pH 9, 45 °C, resulting in a specific enzyme activity of 14.56 U/mg. The products were separated and purified by high-performance counter-current chromatography (HPCCC). Two main components were isolated and identified, 2-amino-2-p-hydroxymethyl-methyl alcohol-benzoate (tirs-benzoate) and 1-benzoyloxy-2,3-propanediol (1-benzoyloxypropane-2,3-diol), via UPLC-Q-TOF-MS and NMR. Additionally, paeoniflorin demonstrated the ability to metabolize into benzoic acid via G6046 enzyme, which might exert antidepressant effects through the blood–brain barrier into the brain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Technology & Business University, Beijing 100048, China.
- College of Chemistry, Beijing Normal University, Beijing 100875, China.
- Beijing Vocational College of Agriculture, Beijing 102442, China.
ORCID-Profile: Hairun Pei, Xueli Cao, Jimin Zheng
Förderung
- National Natural Science Foundation of China
- Beijing Natural Science Foundation and Beijing Municipal Education Committee
Zitieren
APA
Ye, Y., Pei, H., Cao, X., Liu, X., Li, Z., Wang, B., Pan, Y., & Zheng, J. (2023). The Study of a Novel Paeoniflorin-Converting Enzyme from Cunninghamella blakesleeana. Molecules. https://doi.org/10.3390/molecules28031289
Vancouver
Ye Y, Pei H, Cao X, Liu X, Li Z, Wang B, et al. The Study of a Novel Paeoniflorin-Converting Enzyme from Cunninghamella blakesleeana. Molecules. 2023. doi:10.3390/molecules28031289
BibTeX
@article{Ye2023,
author = {Ye, Yiheng and Pei, Hairun and Cao, Xueli and Liu, Xueying and Li, Zhanghan and Wang, Biying and Pan, Yan and Zheng, Jimin},
title = {The Study of a Novel Paeoniflorin-Converting Enzyme from Cunninghamella blakesleeana},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28031289}
}
EUVIMED